Cellular senescence: at the nexus between ageing and diabetes

Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27(5):1047–1053. https://doi.org/10.2337/diacare.27.5.1047 Aronson D, Edelman ER (2014) Coronary artery disease and diabetes mellitus. Cardiol Clin 32(3):439–455. https://doi.org/10.1016/j.ccl.2014.04.001 Morley JE (2018) Diabetes, sarcopenia, and frailty. Clin Geriatr Med 24:455–469 Xu W, Caracciolo B, Wang H-X, Winblad B, Backman L, Qiu C, Fratiglioni L (2010) Accelerated progression from mild cognitive impairment to dementia in people with diabetes. Diabetes 59(11):2928–2935. https://doi.org/10.2337/db10-0539 Kirkland JL (2013) Translating advances from the basic biology of aging into clinical application. Exp Gerontol 48(1):1–5. https://doi.org/10.1016/j.exger.2012.11.014 Kirkland JL (2016) Translating the science of aging into therapeutic interventions. Cold Spring Harb Perspect Med 6(3):a025908. https://doi.org/10.1101/cshperspect.a025908 Kirkland JL, Peterson C (2009) Healthspan, translation, and new outcomes for animal studies of aging. J Gerontol A Biol Sci Med Sci 64:209–212 Kennedy BK, Berger SL, Brunet A et al (2014) Geroscience: linking aging to chronic disease. Cell 159(4):709–713. https://doi.org/10.1016/j.cell.2014.10.039 Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013) The hallmarks of aging. Cell 153(6):1194–1217. https://doi.org/10.1016/j.cell.2013.05.039 Palmer AK, Kirkland JL (2016) Aging and adipose tissue: potential interventions for diabetes and regenerative medicine. Exp Gerontol 86:97–105. https://doi.org/10.1016/j.exger.2016.02.013 Palmer AK, Tchkonia T, LeBrasseur NK, Chini EN, Xu M, Kirkland JL (2015) Cellular senescence in type 2 diabetes: a therapeutic opportunity. Diabetes 64(7):2289–2298. https://doi.org/10.2337/db14-1820 Valdes AM, Andrew T, Gardner JP et al (2005) Obesity, cigarette smoking, and telomere length in women. Lancet 366(9486):662–664. https://doi.org/10.1016/S0140-6736(05)66630-5 Ghosh AK, O’Brien M, Mau T, Yung R (2017) Toll-like receptor 4 (TLR4) deficient mice are protected from adipose tissue inflammation in aging. Aging (Albany NY) 9(9):1971–1982. https://doi.org/10.18632/aging.101288 Furukawa S, Fujita T, Shimabukuro M et al (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114(12):1752–1761. https://doi.org/10.1172/JCI21625 Vlassara H, Palace MR (2002) Diabetes and advanced glycation endproducts. J Intern Med 251(2):87–101. https://doi.org/10.1046/j.1365-2796.2002.00932.x Franceschi C, Campisi J (2014) Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 69(Suppl 1):S4S9 Martyniak K, Masternak MM (2017) Changes in adipose tissue cellular composition during obesity and aging as a cause of metabolic dysregulation. Exp Gerontol 94:59–63. https://doi.org/10.1016/j.exger.2016.12.007 Hammarstedt A, Gogg S, Hedjazifar S, Nerstedt A, Smith U (2018) Impaired adipogenesis and dysfunctional adipose tissue in human hypertrophic obesity. Physiol Rev 98(4):1911–1941. https://doi.org/10.1152/physrev.00034.2017 Kirkland JL, Hollenberg CH, Gillon WS (1990) Age, anatomic site, and the replication and differentiation of adipocyte precursors. Am J Phys 258(2):C206–C210. https://doi.org/10.1152/ajpcell.1990.258.2.C206 Danforth E Jr (2000) Failure of adipocyte differentiation causes type II diabetes mellitus? Nat Genet 26(1):13. https://doi.org/10.1038/79111 Gustafson B, Hammarstedt A, Hedjazifar S, Smith U (2013) Restricted adipogenesis in hypertrophic obesity: the role of WISP2, WNT, and BMP4. Diabetes 62(9):2997–3004. https://doi.org/10.2337/db13-0473 Gustafson B, Hedjazifar S, Gogg S, Hammarstedt A, Smith U (2015) Insulin resistance and impaired adipogenesis. Trends Endocrinol Metab 26(4):193–200. https://doi.org/10.1016/j.tem.2015.01.006 Kim SM, Lun M, Wang M et al (2014) Loss of white adipose hyperplastic potential is associated with enhanced susceptibility to insulin resistance. Cell Metab 20(6):1049–1058. https://doi.org/10.1016/j.cmet.2014.10.010 Palmer AK, Xu M, Zhu Y et al (2019) Targeting senescent cells alleviates obesity-induced metabolic dysfunction. Aging Cell e12950 18(3):e12950. https://doi.org/10.1111/acel.12950 Ogrodnik M, Miwa S, Tchkonia T et al (2017) Cellular senescence drives age-dependent hepatic steatosis. Nat Commun 8(1):15691. https://doi.org/10.1038/ncomms15691 Kirkland JL, Tchkonia T (2017) Cellular senescence: a translational perspective. EBioMedicine 21:21–28. https://doi.org/10.1016/j.ebiom.2017.04.013 Tchkonia T, Zhu Y, van Deursen J, Campisi J, Kirkland JL (2013) Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest 123(3):966–972. https://doi.org/10.1172/JCI64098 Zhu Y, Armstrong JL, Tchkonia T, Kirkland JL (2014) Cellular senescence and the senescent secretory phenotype in age-related chronic diseases. Curr Opin Clin Nutr Metab Care 17(4):324–328. https://doi.org/10.1097/MCO.0000000000000065 Xu M, Pirtskhalava T, Farr JN et al (2018) Senolytics improve physical function and increase lifespan in old age. Nat Med 24(8):1246–1256. https://doi.org/10.1038/s41591-018-0092-9 Minamino T, Orimo M, Shimizu I et al (2009) A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med 15(9):1082–1087. https://doi.org/10.1038/nm.2014 Tchkonia T, Morbeck DE, Von Zglinicki T et al (2010) Fat tissue, aging, and cellular senescence. Aging Cell 9(5):667–684. https://doi.org/10.1111/j.1474-9726.2010.00608.x Hannou SA, Wouters K, Paumelle R, Staels B (2015) Functional genomics of the CDKN2A/B locus in cardiovascular and metabolic disease: what have we learned from GWASs? Trends Endocrinol Metab 26(4):176–184. https://doi.org/10.1016/j.tem.2015.01.008 Krstic J, Reinisch I, Schupp M, Schulz TJ, Prokesch A (2018) p53 functions in adipose tissue metabolism and homeostasis. Int J Mol Sci 19:E2622 Vergoni B, Cornejo PJ, Gilleron J et al (2016) DNA damage and the activation of the p53 pathway mediate alterations in metabolic and secretory functions of adipocytes. Diabetes 65(10):3062–3074. https://doi.org/10.2337/db16-0014 Xu M, Palmer AK, Ding H et al (2015) Targeting senescent cells enhances adipogenesis and metabolic function in old age. Elife 4:e12997. https://doi.org/10.7554/eLife.12997 Zaragosi LE, Wdziekonski B, Villageois P et al (2010) Activin a plays a critical role in proliferation and differentiation of human adipose progenitors. Diabetes 59(10):2513–2521. https://doi.org/10.2337/db10-0013 Kuki S, Imanishi T, Kobayashi K, Matsuo Y, Obana M, Akasaka T (2006) Hyperglycemia accelerated endothelial progenitor cell senescence via the activation of p38 mitogen-activated protein kinase. Circ J 70(8):1076–1081. https://doi.org/10.1253/circj.70.1076 Helman A, Klochendler A, Azazmeh N et al (2016) p16(Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion. Nat Med 22(4):412–420. https://doi.org/10.1038/nm.4054 Thompson PJ, Shah A, Ntranos V, Van Gool F, Atkinson M, Bhushan A (2019) Targeted elimination of senescent beta cells prevents type 1 diabetes. Cell Metab 29(5):1045–1060. https://doi.org/10.1016/j.cmet.2019.01.021 Zhu Y, Tchkonia TT, Pirtskhalava T et al (2015) The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell 14(4):644–658. https://doi.org/10.1111/acel.12344 Tchernof A, Despres JP (2013) Pathophysiology of human visceral obesity: an update. Physiol Rev 93(1):359–404. https://doi.org/10.1152/physrev.00033.2011 Roos CM, Zhang B, Palmer AK et al (2016) Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice. Aging Cell 15(5):973–977. https://doi.org/10.1111/acel.12458 Anderson R, Lagnado A, Maggiorani D et al (2019) Length-independent telomere damage drives post-mitotic cardiomyocyte senescence. EMBO J 38(5):e100492. https://doi.org/10.15252/embj.2018100492 Lewis-McDougall FC, Ruchaya PJ, Domenjo-Villa E et al (2019) Aged-senescent cells contribute to impaired heart regeneration. Aging Cell 18(3):e12931. https://doi.org/10.1111/acel.12931 Verzola D, Gandolfo MT, Gaetani G et al (2008) Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy. Am J Physiol Renal Physiol 295(5):F1563–F1573. https://doi.org/10.1152/ajprenal.90302.2008 Ogrodnik M, Zhu Y, Langhi LGP et al (2019) Obesity-induced cellular senescence drives anxiety and impairs neurogenesis. Cell Metab 29(5):1233–1077.e8. https://doi.org/10.1016/j.cmet.2018.12.008 Musi N, Valentine JM, Sickora KR et al (2018) Tau protein aggregation is associated with cellular senescence in the brain. Aging Cell 17(6):e12840. https://doi.org/10.1111/acel.12840 Zhang P, Kishimoto Y, Grammatikakis I et al (2019) Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer’s disease model. Nat Neurosci 22(5):719–728. https://doi.org/10.1038/s41593-019-0372-9 Justice J, Miller JD, Newman JC et al (2016) Frameworks for proof-of-concept clinical trials of interventions that target fundamental aging processes. J Gerontol A Biol Sci Med Sci 71(11):1415–1423. https://doi.org/10.1093/gerona/glw126 Kirkland JL, Tchkonia T, Zhu Y, Niedernhofer LJ, Robbins PD (2017) The clinical potential of senolytic drugs. J Am Geriatr Soc 65(10):2297–2301. https://doi.org/10.1111/jgs.14969 Tchkonia T, Kirkland JL (2018) Aging, cell senescence, and chronic disease: emerging therapeutic strategies. JAMA 320(13):1319–1320. https://doi.org/10.1001/jama.2018.12440 Yousefzadeh MJ, Zhu Y, McGowan SJ et al (2018) Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine 36:18–28. https://doi.org/10.1016/j.ebiom.2018.09.015 Justice JN, Nambiar AM, Tchkonia T et al (2019) Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study. EBioMedicine 40:554–563. https://doi.org/10.1016/j.ebiom.2018.12.052